Search result

Phantom 4 RTK/feed/category/dji-mavic-3e-pl- Page 176

NVIDIA’s Stock Soars to New Highs – Analysts Eye Further Gains

Nvidia Stock Today (NVDA) on November 19, 2025: Shares Jump After Record $57 Billion Q3 Revenue and Bullish AI Outlook

Nvidia reported fiscal Q3 2026 revenue of $57.0 billion and net income of $31.9 billion, both record highs, beating Wall Street estimates. Shares closed up nearly 3% at $186.52 and surged another 4–5% after hours. Data Center revenue reached $51.2 billion, up 25% from the previous quarter. The results reversed part of Nvidia’s earlier November stock pullback.
20 November 2025
MercadoLibre (MELI) Stock Today: Sharp Pullback, New Shelf Filing and Fresh Institutional Moves – 20 November 2025

MercadoLibre (MELI) Stock Today: Sharp Pullback, New Shelf Filing and Fresh Institutional Moves – 20 November 2025

MercadoLibre shares fell about 4% to $1,993.91 on November 20, 2025, extending recent declines despite new institutional buying reported in fresh 13F filings. The company’s market cap stands near $105 billion, with technical indicators showing a “strong sell” for the day. A new mixed shelf registration was also filed, raising expectations for future moves.
20 November 2025
Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates

Novo Nordisk Stock on 21 November 2025: NVO Slips as Denmark Grants Eye-Damage Payouts and GLP‑1 Price War Escalates

Novo Nordisk’s U.S. shares fell 1.1% to $47.07 by late morning, while Copenhagen B-shares closed down nearly 3% at DKK 305, extending a year-to-date drop of about 45%. Denmark compensated four patients for vision loss linked to Wegovy and Ozempic. Novo Nordisk and Eli Lilly launched direct-to-employer GLP-1 drug programs, and Novo cut self-pay prices for its weight-loss drugs.
NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know

NeuBase Therapeutics dissolved and began liquidation after filing a Certificate of Dissolution on June 26, 2024. Nasdaq delisted NBSE in May 2024; trading was suspended and shares are no longer listed on any exchange. Shareholders received $0.13 per share and a non-tradable escrow share for potential future payouts. No active market exists, despite some data vendors still showing outdated prices.
23 November 2025
1 174 175 176

Stock Market Today

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

Kein IRS-Stimulus-Scheck über 2.000 Dollar kommt im Februar 2026 – aber Trumps Gerede über Zoll-Schecks hält die Gerüchte am Leben

7 Februar 2026
Für Februar 2026 sind keine neuen bundesweiten Stimulus-Schecks geplant, der IRS hat keine Ankündigung gemacht und der Kongress keine Zahlungen genehmigt. Trump prüft laut NBC $2.000 Tarif-Rabatt-Schecks, hat sich aber nicht festgelegt. Der IRS warnt vor Betrugsversuchen per SMS oder E-Mail. Social-Media-Gerüchte über neue Schecks halten an.
Go toTop